Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewN-(4-Bromobenzyl)-5-methoxytryptamine oxalate
说明： 5-HT2A ligand
生物活性
Very potent and selective ligand at 5-HT2A receptors (Ki = 0.1 nM).
技术数据
| 分子量 | 449.3 |
| 储存 | Desiccate at +4°C |
上方提供的技术数据仅供参考。批次相关数据请参见分析证书。
Tocris products are intended for laboratory research use only, unless stated otherwise.
产品说明书
分析证书目前不在网上提供。
请联系客户服务
请联系客户服务
参考文献
参考文献是支持产品生物活性的出版物。
Glennon et al (1994) Influence of amine substituents on 5-HT2A versus 5-HT2C binding of phenylalkyl- and indolylalkylamines. J.Med.Chem. 37 1929 PMID: 8027974
按标靶查看相关产品
按产品操作查看相关产品
关键词: N-(4-Bromobenzyl)-5-methoxytryptamine oxalate, N-(4-Bromobenzyl)-5-methoxytryptamine oxalate supplier, 5-HT2A, Receptors, 0755, Tocris Bioscience
篇 N-(4-Bromobenzyl)-5-methoxytryptamine oxalate 的引用文献
引用文献是使用了 Tocris 产品的出版物。
目前没有 N-(4-Bromobenzyl)-5-methoxytryptamine oxalate 的引用文献。
N-(4-Bromobenzyl)-5-methoxytryptamine oxalate 的评论
目前没有该产品的评论。 Be the first to review N-(4-Bromobenzyl)-5-methoxytryptamine oxalate and earn rewards!
Have you used N-(4-Bromobenzyl)-5-methoxytryptamine oxalate?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
该领域的文献
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*请注意，Tocris 仅会向正规科研企业/机构地址发送文献。
5-HT Receptors Scientific Review
Written by Nicholas M. Barnes and John F. Neumaier, this review summarizes the various serotonin receptor subtypes and their importance in mediating the role of serotonin in numerous physiological and pharmacological processes. Compounds available from Tocris are listed.
Depression Poster
Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.
Parkinson's Disease Poster
Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.